In this study, researchers aimed to identify endometrial cancer patient preferences and gather insights on how these preferences might inform treatment decisions.
A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results